Brian Skorney is one of Robert W. Baird & Co.’s Senior Analysts covering biotechnology. Mr. Skorney has followed the sector for six years, most recently at Brean Murray Carret & Co. Prior to his career in equity research, Mr. Skorney worked in medical research. Mr. Skorney received a B.S. in biological sciences from the University of Notre Dame and an MBA in finance from the Stern School of Business at New York University.
Biotechnology Capital Inflows Reach Historic Highs
April 07, 2014